This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Varian & Tata Trust Tie Up to Boost Radiotherapy in India
by Zacks Equity Research
Varian's (VAR) three-year deal with Tata Trust is likely to fortify its foothold in the Asia-Pacific radiotherapy space.
Zacks.com featured highlights include: Oaktree Capital, Synopsys, Starbucks, Stryker and Ares Capital
by Zacks Equity Research
Zacks.com featured highlights include: Oaktree Capital, Synopsys, Starbucks, Stryker and Ares Capital
Zacks.com featured highlights include: Core-Mark, Progressive, Casey???s, Stryker and Intuit
by Zacks Equity Research
Zacks.com featured highlights include: Core-Mark, Progressive, Casey???s, Stryker and Intuit
Moving Average Crossover Alert: Stryker
by Zacks Equity Research
Stryker Corporation (SYK) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Impressive Sales Growth Makes These 5 Stocks Worth Buying
by Zacks Equity Research
Sales growth is an important metric for any company as it is a vital part of growth projections and is instrumental in strategic decision-making.
5 Dividend Growth Stocks Poised for Outperformance
by Sweta Killa
The Fed's shift to a patient approach on interest rates after lifting-off rates for three years has brought back the lure for dividend investing this year.
Stock Market News For Feb 26, 2019
by Zacks Equity Research
Wall Street rally continued on Monday following positive developments on the trade war front.
Stryker Expands Acquisition Portfolio With Arrinex Buyout
by Zacks Equity Research
Stryker's (SYK) latest buyout is expected to boost its Neurotechnology & Spine business.
Integer Holdings' (ITGR) 2019 View Strong Despite Rivalry
by Zacks Equity Research
Integer Holdings (ITGR) holds a solid position in the MedTech space but is still exposed to competition.
Zacks.com featured highlights include: Oshkosh, Allison Transmission, LPL and Stryker
by Zacks Equity Research
Zacks.com featured highlights include: Oshkosh, Allison Transmission, LPL and Stryker
4 GARP Stocks to Scoop Up for Maximum Returns
by Zacks Equity Research
If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.
Is Stryker (SYK) a Solid Growth Stock? 3 Reasons to Think " Yes "
by Zacks Equity Research
Stryker (SYK) could produce exceptional returns because of its solid growth attributes.
Stryker (SYK) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Stryker (SYK) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here's Why You Should Invest in Stryker (SYK) Stock Right Now
by Zacks Equity Research
Stryker's (SYK) strong guidance for the first quarter of 2019 buoys optimism in the stock.
Bright Near-Term Outlook for Medical Instruments Industry
by Zacks Equity Research
Growing medical awareness and economic prosperity have been enhancing the uptake of medical instruments in the emerging economies.
Stock Market News For Jan 30, 2019
by Zacks Equity Research
U.S. stocks closed mostly lower as trade war concerns escalated further.
Stryker (SYK) Q4 Earnings Beat, International Revenues Surge
by Zacks Equity Research
Stryker (SYK) gains from solid segmental contributions in Q4.
Medical Products Industry Outlook: Plenty of Upside Left
by Zacks Equity Research
The growing adoption of AI, Medical Mechatronics & Robotics has lent the Medical Products industry a competitive edge in the broader medical market.
Will Core MedSurg Segment Aid Stryker's (SYK) Q4 Earnings?
by Zacks Equity Research
Stryker's (SYK) Q4 results are likely to be aided by its core MedSurg segment.
The Zacks Analyst Blog Highlights: UnitedHealth, CVS, General Electric, ExxonMobil and Stryker
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, CVS, General Electric, ExxonMobil and Stryker
Top Analyst Reports for UnitedHealth, CVS Health & General Electric
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), CVS Health (CVS) and General Electric (GE).
Why the Earnings Surprise Streak Could Continue for Stryker (SYK)
by Zacks Equity Research
Stryker (SYK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
SYK vs. SRDX: Which MedTech Stock Should Investors Pick?
by Zacks Equity Research
Surmodics (SRDX) scores higher than Stryker (SYK) in terms of current-year revenue projections and fundamentals.
Here's Why You Should Invest in Stryker (SYK) Stock Right Now
by Zacks Equity Research
Stryker (SYK) continues to gain from its Mako robotics platform, which has been the key driver of the company's core Orthopaedic segment.
Cerner's (CERN) Millennium Picked by Mid-Valley Hospital
by Zacks Equity Research
Cerner's (CERN) EHR platforms have seen a series of developments in recent times.